effects of igf-1 lr3 IGF-1, the Cross Road the Nutritional, Inflammatory and Hormonal Pathways to Frailty Unlocking the Power of IGF-1
Description
Use of intravenous iron therapy in colorectal cancer patient with iron deficiency anemia: a propensity-score matched study
Acivicin treatment (24 h) significantly decreased mEPSC frequency (Fig
This involves interaction with the virus entry receptor Nectin-1 and the entry mediators NMHC-IIA/B
Efinopegdutide has been granted fast track designation by the FDA for the treatment of MASH (NCT04944992, NCT05877547) and this is the indication that the clinical development programme of this molecule will focus
Brain nitric oxide changes after controlled cortical impact injury in rats
